Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Erik Soeren Halvard Hansen, Amalie Lykkemark Moeller, Vibeke Backer, Mikkel Porsborg Andersen, Lars Kober, Kristian Kragholm, Christian Torp-Pedersen. Severe outcomes of COVID-19 among patients with COPD and asthma. ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020

Member's Comments

No comment yet.

Related content which might interest you: Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations Source: International Congress 2014 – COPD markers Year: 2014 Anemia in COPD patients with an exacerbation Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Sexuality in patients with asthma and/or COPD Source: Eur Respir J 2003; 22: Suppl. 45, 54s Year: 2003 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Cognitive impairment in patients hospitalized with acute COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma Year: 2014